HomeARX • ASX
add
Aroa Biosurgery Ltd
Nakaraang pagsara
$0.52
Sakop ng araw
$0.52 - $0.54
Sakop ng taon
$0.35 - $0.82
Market cap
177.44M AUD
Average na Volume
263.51K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (NZD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 22.77M | 22.44% |
Gastos sa pagpapatakbo | 18.31M | -1.38% |
Net na kita | -259.50K | 87.99% |
Net profit margin | -1.14 | 90.19% |
Kita sa bawat share | — | — |
EBITDA | 1.80M | 206.79% |
Aktuwal na % ng binabayarang buwis | -50.43% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (NZD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 22.15M | -26.72% |
Kabuuang asset | 108.87M | -1.97% |
Kabuuang sagutin | 15.79M | -2.06% |
Kabuuang equity | 93.08M | — |
Natitirang share | 344.90M | — |
Presyo para makapag-book | 1.91 | — |
Return on assets | 2.31% | — |
Return on capital | 2.52% | — |
Cash Flow
Net change in cash
| (NZD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -259.50K | 87.99% |
Cash mula sa mga operasyon | 1.15M | 3,212.16% |
Cash mula sa pag-invest | -3.75M | -191.43% |
Cash mula sa financing | -376.00K | -57.32% |
Net change in cash | -2.80M | -174.12% |
Malayang cash flow | 2.87M | 1,633.63% |
Tungkol
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, USA and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward.
The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
Itinatag
2008
Website
Mga Empleyado
261
